ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      6,040.53
      -0.50%
      US Tech 100
      20,778.00
      -0.69%
      Dow Jones
      44,544.66
      -0.75%
      Brent Oil
      76.385
      0.00%
      Bitcoin
      102,049.11
      -0.36%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ

      6. NLS Pharmaceutics Ltd (NLSP) Quote

      NLS Pharmaceutics Ltd

      NLS Pharmaceutics Ltd (NLSP)

      NASDAQ
      2.49
      0.51
      (25.76%)
      Closed February 01 4:00PM
      Delayed by 15 minutes
      2.39
      -0.10
      (-4.02%)
      After Hours: 7:59PM
      Delayed by 15 minutes

      Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

      Premium

      Key stats and details

      Current Price
      2.39
      Bid
      1.78
      Ask
      2.57
      Volume
      61,242,764
      2.29 Day's Range 3.37
      1.71 52 Week Range 20.80
      Previous Close
      1.98
      Open
      3.01
      Last Trade
      10
      @
      2.46
      Last Trade Time
      Average Volume (3m)
      1,086,271
      Financial Volume
      $ 156,502,184
      VWAP
      2.5554

      Ask ADVFN Intelligence (AI)

      NLSP Latest News

      More News

      Kadimastem Shareholders Approved the Merger with NLS Pharmaceutics

      Kadimastem Shareholders Approved the Merger with NLS Pharmaceutics PR Newswire ZURICH and NESS ZIONA, Israel, Jan. 31, 2025 ZURICH and NESS ZIONA, Israel, Jan. 31, 2025 /PRNewswire/ -- NLS...

      January 31 2025
      PR Newswire (US)

      NLS Pharmaceutics Announces the Submission of Three Research Abstracts to the 2025 ASCP Annual Meeting

      NLS Pharmaceutics Announces the Submission of Three Research Abstracts to the 2025 ASCP Annual Meeting PR Newswire ZURICH, Jan. 30, 2025 ZURICH, Jan. 30, 2025 /PRNewswire/ -- NLS Pharmaceutics...

      January 30 2025
      PR Newswire (US)

      NLS Pharmaceutics Announces the Launch of a Preclinical Program for Mazindol ER in the Treatment of Fentanyl Dependence

      NLS Pharmaceutics Announces the Launch of a Preclinical Program for Mazindol ER in the Treatment of Fentanyl Dependence PR Newswire ZURICH, Jan. 28, 2025 Centers for Disease Control and...

      January 28 2025
      PR Newswire (US)

      Kadimastem Calls for a Special General Meeting of Shareholders to Approve the Merger with NLS

      Kadimastem Calls for a Special General Meeting of Shareholders to Approve the Merger with NLS PR Newswire ZURICH and NESS ZIONA, Israel, Jan. 16, 2025 Kadimastem Approaches Final Steps for...

      January 16 2025
      PR Newswire (US)

      NLS Pharmaceutics Ltd. and Kadimastem Ltd. Announce the Initial Closing of $500,000 of the Previously Announced $1 Million Fundraising by NLS Following its Extraordinary General Meeting at a Share Price of $3.10, Representing 48% Above the Market Share Pri

      NLS Pharmaceutics Ltd. and Kadimastem Ltd. Announce the Initial Closing of $500,000 of the Previously Announced $1 Million Fundraising by NLS Following its Extraordinary General Meeting at a...

      January 08 2025
      PR Newswire (US)

      NLS Pharmaceutics Ltd. and Kadimastem Ltd. Announce Filing of F-4 Registration Statement with the SEC Ahead of Proposed Merger

      NLS Pharmaceutics Ltd. and Kadimastem Ltd. Announce Filing of F-4 Registration Statement with the SEC Ahead of Proposed Merger PR Newswire ZURICH and NESS ZIONA, Israel, Dec. 30, 2024 The...

      December 30 2024
      PR Newswire (US)

      NLS Pharmaceutics Ltd. Announces Pricing of Private Placement of up to $1 Million at a 15% Premium to the Market

      NLS Pharmaceutics Ltd. Announces Pricing of Private Placement of up to $1 Million at a 15% Premium to the Market PR Newswire ZURICH, Dec. 4, 2024 ZURICH, Dec. 4, 2024 /PRNewswire/ -- NLS...

      December 04 2024
      PR Newswire (US)

      Form F-1 - Registration statement for certain foreign private issuers

      August 27 2024
      Edgar (US Regulatory)

      Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

      August 26 2024
      Edgar (US Regulatory)

      Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

      August 15 2024
      Edgar (US Regulatory)
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      10.5932.77777777781.82.571.7114111031.88510291CS
      40.2712.73584905662.122.71.7115558992.24781109CS
      12-1.69-41.42156862754.084.151.7110862712.44637842CS
      26-6.81-74.02173913049.29.21.717738293.84089471CS
      52-16.186-87.133936261818.57620.81.7134920228.77304574CS
      156-32.01-93.052325581434.475.21.71133209211.56860579CS
      260-115.61-97.97457627121182941.71163910269.5531594CS

      NLSP - Frequently Asked Questions (FAQ)

      What is the current NLS Pharmaceutics share price?
      The current share price of NLS Pharmaceutics is $ 2.39
      What is the 1 year trading range for NLS Pharmaceutics share price?
      NLS Pharmaceutics has traded in the range of $ 1.71 to $ 20.80 during the past year

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      TCTMTCTM Kids IT Education Inc
      $ 0.764
      (321.87%)
      		729.72M
      REBNReborn Coffee Inc
      $ 3.31
      (63.05%)
      		55.54M
      FCUVFocus Universal Inc
      $ 5.87
      (56.62%)
      		1.73M
      SOPASociety Pass Inc
      $ 1.54
      (56.50%)
      		13.82M
      CYCNCyclerion Therapeutics Inc
      $ 3.92
      (54.33%)
      		82.39M
      ENVBEnveric Biosciences Inc
      $ 2.0899
      (-46.41%)
      		1.58M
      NIVFNewGenIvf Group Ltd
      $ 0.1489
      (-42.51%)
      		14.91M
      GLSTGlobal Star Acquisition Inc
      $ 8.83
      (-39.10%)
      		23.93k
      PRPHProPhase Labs Inc
      $ 0.2633
      (-38.02%)
      		900.48k
      SPGCSacks Parente Golf Inc
      $ 0.5601
      (-37.86%)
      		7.42M
      TCTMTCTM Kids IT Education Inc
      $ 0.764
      (321.87%)
      		729.72M
      NVDANVIDIA Corporation
      $ 120.07
      (-3.67%)
      		388.54M
      RIMEAlgorhythm Holdings Inc
      $ 0.02565
      (5.12%)
      		338.75M
      BHATBlue Hat Interactive Entertainment Technology
      $ 0.0355
      (-11.25%)
      		236.29M
      CLEUChina Liberal Education Holdings Ltd
      $ 0.1938
      (30.77%)
      		234.8M

      Discussion

      View Full Feed
      No Posts Found

      Your Recent History

      NASDAQ
      NLSP
      NLS Pharmaceutics
      Delayed Upgrade Clock

      Go Ad-Free

      Subscribe to Ad free and enjoy an ad-free experience

      No Ads

      Try Now

      Keep the Ads